IRF4

IRF4, also known as interferon regulatory factor 4, is a transcription factor that plays a crucial role in hematopoiesis and immune response regulation. It functions as a central mediator of TCR signals and is involved in various signaling pathways, including those related to B-cell development and differentiation. IRF4 is implicated in the pathogenesis of multiple myeloma, chronic lymphocytic leukemia, and adult T-cell leukemia/lymphoma. Its expression is often associated with poor prognosis in these diseases. Research on IRF4 has led to the development of potential therapeutic strategies, including targeting its expression or function to inhibit tumor growth and progression.